Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Ninlaro
Asia
Legend IPO, China reliance, Harbour-Mount Sinai—FiercePharmaAsia
J&J CAR-T partner Legend aims for U.S. IPO. The FDA's not sure how many drugs and APIs come from China. Harbour teams with Mount Sinai on coronavirus.
Angus Liu
Mar 13, 2020 10:26am
Takeda's Ninlaro swings and misses in newly diagnosed myeloma
Mar 10, 2020 12:39pm
AZ-Daiichi, J&J-Legend, Samsung and more—FiercePharmaAsia
Dec 13, 2019 8:48am
Takeda details Ninlaro's miss in AL amyloidosis
Dec 9, 2019 3:41am
Takeda scores a win for Ninlaro in multiple myeloma
Nov 8, 2019 9:54am
Takeda swings and misses with Ninlaro in AL amyloidosis
Jun 6, 2019 12:41pm
